Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tiny particles may hold key to predicting rectal cancer outcomes

NCT ID NCT03874559

First seen May 09, 2026 · Last updated May 21, 2026 · Updated 3 times

Summary

This study is looking at tiny particles called exosomes in the blood of people with rectal cancer. The goal is to see if these particles can help predict how well a patient responds to chemotherapy and radiation before surgery. Researchers will compare exosome levels before, during, and after treatment with the actual results from surgery. The study involves 30 adults with rectal cancer who are scheduled for standard treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Kansas Medical Center/ Cancer Center

    RECRUITING

    Kansas City, Kansas, 66190, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.